Brakes Put On Brandname Pharmaceuticals: Sales Set for Substantial Slowdown

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.4, Iss.10, 2006-01, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Global drug sales rising but set to slow down in 2002

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Therapeutic Boost for Atrial Fibrillation Market: Three New Class III Drugs Set to Triple Sales

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 8, 2006-01 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

The battle between brand-name and generic drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 501, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Paracetamol price cuts for brandname products in France

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Sales of human epidermal growth factor receptor 2 (HER2)-targeting breast cancer therapies are set to grow by 3.3% per annum

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite